CRH Medical Corp. Daily Stock Analysis

Daily Stock Analysis, CRHM, CRH Medical Corp, priceseries

CRH Medical Corp. Daily Stock Analysis
Stock Information
Open
2.79
Close
2.77
High
2.80
Low
2.75
Previous Close
2.79
Daily Price Gain
-0.02
YTD High
3.43
YTD High Date
Feb 5, 2019
YTD Low
2.51
YTD Low Date
Mar 25, 2019
YTD Price Change
-0.42
YTD Gain
-13.17%
52 Week High
4.50
52 Week High Date
Sep 12, 2018
52 Week Low
2.51
52 Week Low Date
Mar 25, 2019
52 Week Price Change
-0.38
52 Week Gain
-12.06%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
5.45
Jan 18. 2017
5.92
10 Trading Days
8.67%
Link
LONG
Feb 21. 2017
6.60
Mar 21. 2017
7.96
20 Trading Days
20.55%
Link
LONG
Dec 1. 2017
2.00
Dec 13. 2017
2.15
8 Trading Days
7.56%
Link
LONG
May 8. 2018
3.20
May 24. 2018
3.42
12 Trading Days
6.77%
Link
LONG
Jul 27. 2018
3.25
Sep 4. 2018
4.06
26 Trading Days
24.97%
Link
Company Information
Stock Symbol
CRHM
Exchange
NYSE MKT
Company URL
http://www.crhmedcorp.com
Company Phone
-
CEO
Edward Wright
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
-
Industry Group
-
CIK
-
About

CRH Medical Corp. provides physicians with innovative products for the treatment of gastrointestinal diseases. It focuses on physician education, patient outcomes and patient awareness. The company's product, the CRH ORegan System, is a single use, disposable, hemorrhoid treatment. It delivers clinical, marketing and operational support directly to its partner physicians. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Description

N/A

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading